Dermatophytic Onychomycosis Therapeutics Market to grow based on digitized impertinence at a CAGR of 6.5%
Dermatophytic onychomycosis also known as tinea guinea can have certain negative effects on patients, such as pain, and can potentially undermine their work and social lives. Moreover, the infection might spread to the surrounding skin.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/5840
Moberg Pharma AB
Dr. Reddy's Laboratories Ltd.
Medimetriks Pharmaceuticals, Inc.
Teva Pharmaceutical industries Ltd.
Cardinal Health Inc.
The condition isn't considered life-threatening but may result in physical and occupational limitations, because of which more and more people are opting for the treatment of their infected, thick, and cracked nails. This, in turn, is driving the growth of the market for dermatophytic onychomycosis therapeutics.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5840
The global dermatophytic onychomycosis therapeutics market based on product type has been segmented into tablets and nail paints, which is again sub-segmented into prescription (Rx) and over-the-counter. The nail paint segment is expected to contribute maximum share in the global dermatophytic onychomycosis therapeutics market and expand at a CAGR of 8.1% during the forecast period.
Based on treatment type, the global dermatophytic onychomycosis therapeutics market has been segmented into topical and oral. The topical is projected to be the dominant segment throughout the forecast period, accounting for around 70% share of the global dermatophytic onychomycosis therapeutics market by 2026.
Based on end users, the global dermatophytic onychomycosis therapeutics market has been segmented into hospitals, clinics, independent pharmacies, mail order pharmacies and drug stores. The drug stores & independent pharmacies segments are estimated to be the large segments, which collectively accounted approximately 54% share of the global dermatophytic onychomycosis therapeutics market in 2017.
The independent pharmacies segment is expected to register a high CAGR growth during the forecast period. The drug stores was the second most attractive segment in the global dermatophytic onychomycosis therapeutics market in 2017.
The growth of the market is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Dermatophytic onychomycosis is common in the elderly, with prevalence rates as high as 20% in those over 60 years of age and 30% in those over 70.
Thus increasing geriatric population is the most important factor that is expected to drive growth of the dermatophytic onychomycosis therapeutics market over the forecast period. Easy application of nail paints is also expected to drive the demand for dermatophytic onychomycosis therapeutics.
Another factor fueling the growth of dermatophytic onychomycosis therapeutics market is the growing preference of dermatophytic onychomycosis therapeutics by podiatrists and dermatologists.
Rise in diagnosis of the nail infection has raised awareness regarding the fungal infection of nails and dermatophytic onychomycosis therapeutics. Besides, increasing awareness regarding dermatophytic onychomycosis therapeutics amongst podiatrists and dermatologists has led to a rise in demand for effective medications. However, adverse effects such as headache, dizziness, nausea, stomach ache, etc., associated with antifungal drugs have made people more skeptical about practicing a systemic therapy for nails.
Moreover, the topical agents also causes rash and itchiness in the surrounding skin. These side effects are hampering the acceptance of dermatophytic onychomycosis therapeutics for the treatment of moderate to severe dermatophytic onychomycosis associated with anti-fungal therapeutics. Another factor impeding the growth of dermatophytic onychomycosis therapeutics is lack of awareness regarding dermatophytic onychomycosis therapeutics and dermatophytic onychomycosis itself.
There is a general lack of awareness regarding the disease, its possible causes, symptoms etc. People in some African, European, Gulf, and Asian countries are still ignorant about their diseased nails. There is a general perception among patients that the thickened nail would get cured by itself after sometime. Thus, lack of awareness is also a major factor hindering growth of the onychomycosis therapeutics market currently.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/5840
Geographically, the global dermatophytic onychomycosis therapeutics market is segmented into five major regions, namely North America, Latin America, Europe, Asia Pacific, and Middle East & Africa (MEA). North America was the dominant regional market for dermatophytic onychomycosis therapeutics and is expected to follow the same trend over the forecast period.
The Europe market for dermatophytic onychomycosis therapeutics is expected to account for second large share followed by Asia Pacific. North America and Europe collectively are expected to account for over 60% share of the global dermatophytic onychomycosis therapeutics market over the forecast period. MEA and Latin America are expected to be the fast-growing regions in the global dermatophytic onychomycosis therapeutics market due to growing healthcare efforts.
Access PMR Exclusive Reports-
CCTV Camera Market- https://www.persistencemarketresearch.com/market-research/cctv-cameras-market.asp
Computer Accessories Market- https://www.persistencemarketresearch.com/market-research/computer-accessories-market.asp
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - email@example.com
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dermatophytic Onychomycosis Therapeutics Market to grow based on digitized impertinence at a CAGR of 6.5% here
News-ID: 2668283 • Views: 205
More Releases from Persistence Market Research
The 4G LTE Devices Market To Witness An Innovative Statute
In terms of value, the global 4G (LTE) devices market is projected to register an astronomical CAGR of 16.7% during the forecast period of 2021 to 2031, owing to various factors, regarding which, Persistence Market Research offers vital insights in detail. The industry is anticipated to top a valuation of approximately US$ 185 Bn by the end of 2031. Request for Free Sample Report of "4G LTE Devices" Market@ https://www.persistencemarketresearch.com/samples/10466
Innovative Turmoil To Run Through The Sonobuoy Market
The global sonobuoy market is anticipated to grow from a valuation of US$ 324.7 Mn in 2021 to close to US$ 600 Mn by 2031, expanding at a CAGR of 6.3% in terms of revenue. In this revised report, the global market is tracked in terms of value and is calibrated to obtain market revenue estimates. Sonobuoys are acoustic sensors built on the principle of Sound Navigation and Ranging (SONAR) system,
The Imaging Technology For Precision Agriculture Market To Witness Germination O …
A recently revised study by Persistence Market Research has projected that demand for imaging technology for precision agriculture will rise at a notable CAGR of 8.8% during the forecast period of 2021 to 2031, by the end of which opportunities in the market are estimated to translate to a revenue of US$ 1.7 Bn. Analysts of the report have notified that the market for imaging technology in precision agriculture produced a
The Mobile Applications Market To Move Through Glossy Innovation
The global mobile applications market is currently valued at US$ 112.6 Bn, and is predicted to reach a worth of over US$ 307 Bn by the end of the forecast period (2021 - 2031). The market is projected to rise at a CAGR of 12.4% over the next ten years. Leading players operating in the global mobile applications market are Apple Inc., Google LLC, Samsung Electronics Co. Ltd., China Mobile Limited,